Skip to main content
29 April, 2020

Hyris Ltd on Immunological Reviews - Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment

We are proud of our last result, a publication on Immunological Reviews of the paper “Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment”.

The realization of this publication represents a milestone and praise the inestimable contributes of two important researcher: Dr. Federico Martinelli (Department of Biology, Università degli studi di Firenze, Firenze, Italy) and Dr. Anna Perrone (Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy) .

The article evaluates the pandemic we’re living and the screening methodologies available at the moment proposing the bCUBE as a viable alternative for a quick and simple detection of this virus in humans.


  • Hyris signs a distribution agreement with GrowBIGogh

  • Hyris technology supports the fight against one of the world’s deadliest diseases, malaria.

  • Hyris fulfils its integration into Ulisse Biomed to give birth to a new international group ready to make its mark in the global biotech market.

  • Distribution agreement renewal with Biomol Laboratories, fostering the partnership in the field of personalised medicine

  • Hyris' signed a binding agreement for a reverse take-over, leading to a new integrated entity with Ulisse Biomed

  • Hyris' new onboarding programs support researchers and developers to launch testing kits.

  • Hyris Founder&CEO Stefano Lo Priore interviewed by Carter&Benson

  • Hyris and Singlabs signed a distributorship agreement for Singapore

  • Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.

  • Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine